Marjolein P. Schoonakker

Statistics

Publications

Citations

149

H-Index

Active since

2016

Affiliations

Leiden University Medical Center(Current)

Sanquin

Netherlands Metabolomics Centre

IFOM

University of Southern California

Marjolein P. Schoonakker is an author at Leiden University Medical Center specializing in diabetes mellitus, diabetes diet therapy, and immunotherapy.

ORCID

Publications per year

2016–2024

Publications

TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1

Lorenz Jahn, Pleun Hombrink, Renate S. Hagedoorn et al. · Blood · 2017 · 56 citations · Full text

Medicine, Immunology, Oncology +16

Fasting in diabetes treatment (FIT) trial: study protocol for a randomised, controlled, assessor-blinded intervention trial on the effects of intermittent use of a fasting-mimicking diet in patients with type 2 diabetes

Elske L. van den Burg, Marjolein P. Schoonakker, Petra G. van Peet et al. · BMC Endocrine Disorders · 2020 · 26 citations · Full text

Agriculture, Endocrinology, Nutrition +17

Generation of CD20-specific TCRs for TCR gene therapy of CD20low B-cell malignancies insusceptible to CD20-targeting antibodies

Lorenz Jahn, Dirk M. van der Steen, Renate S. Hagedoorn et al. · Oncotarget · 2016 · 25 citations · Full text

Life Sciences, Immunology, Oncology +17

Integration of a fasting-mimicking diet programme in primary care for type 2 diabetes reduces the need for medication and improves glycaemic control: a 12-month randomised controlled trial

Elske L. van den Burg, Marjolein P. Schoonakker, Petra G. van Peet et al. · Diabetologia · 2024 · 20 citations · Full text

Medicine, Internal Medicine, Clinical Nutrition +15

A CD22-reactive TCR from the T-cell allorepertoire for the treatment of acute lymphoblastic leukemia by TCR gene transfer

Lorenz Jahn, Renate S. Hagedoorn, Dirk M. van der Steen et al. · Oncotarget · 2016 · 12 citations · Full text

Medicine, Hematology, Immunology +13

1–5 of 6